MADRID, Apr 8. (EUROPA PRESS) –
The Carlos III Health Institute (ISCIII) participates in the ‘EU-Africa PerMed Project’ which aims to promote the development and implementation of personalized medicine on a global scale between the European Union and Africa.
The initiative is funded by ‘Horizon 2020’ and seeks to promote joint projects and programs of personalized medicine between Europe and Africa, as well as the strengthening of bilateral relations of science, technology and innovation in the area of health. The ISCIII, one of the many organizations participating in the project, coordinates two of its main lines of work.
At the launch meeting of the program, which was held last month, the first steps were taken to promote the integration of African countries in the activities of the International Consortium for Personalized Medicine (ICPerMed).
The project, conceived and designed in the midst of the coronavirus outbreak, responds to the need for global approaches to global threats. The implementation and development of the project is based on six work packages that seek to identify and involve relevant organizations related to health and promote the integration of funding structures and political organizations in ICPerMed.
In addition, it will align with the activities of the EU-Africa research programs that are already underway, and with other bi-regional political actions. Specifically, over the next 4 years, the EU-Africa PerMed project will be developed by 13 organizations from both Europe (6 partners) and Africa (7 partners).
The ISCIII participates by co-leading the communication and dissemination activities of the project, together with the intergovernmental organization ECSA-HC (Health Community of Eastern, Central and Southern Africa), which encourages and promotes regional cooperation in health among member states.
Likewise, the ISCIII is also responsible for promoting the integration of African funding bodies in ‘ERA PerMed’, an initiative led by the Institute and co-financed by the European Union that coordinates and joins the efforts of its 32 partners to finance transnational research projects in medicine. personalized.
Precision medicine is one of the areas with the greatest involvement of the ISCIII. In addition to coordinating ERA PerMed since 2017, an international initiative on personalized medicine in which the main national agencies that finance biomedical research participate, the ISCIII has launched the Call for granting grants for the Precision Medicine Infrastructure associated with Science and Technology ( IMPaCT), as part of the Strategic Action in Health 2017-2020 of the ISCIII.
The granting of these grants for the IMPaCT call, for a total value of 25.8 million euros, represents a new step towards the implementation of precision medicine in the National Health System through a strategy based on science and innovation, which will have 77.3 million euros for its development in the next two years. The programs included in IMPaCT are aligned with several areas that will be developed in the future national strategy: Predictive Medicine; Genomic Medicine and Data Science.
Among other initiatives, the ISCIII is also involved in the European project ‘PERMIT’, which works in the search for methodological improvements that facilitate the development and implementation of precision medicine, and in the ‘Initiative 1+ Million Genomes’, which seeks generate standardized and secure genomic information available to be shared at the European level under a federated access platform; The objective is to consolidate a collaborative project on genomic information to achieve advances in research, disease prevention, best clinical practices and treatment customization.